Increase rate of ruptured tubal ectopic pregnancy during the COVID-19 pandemic.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 15 10 2020
revised: 18 01 2021
accepted: 27 01 2021
pubmed: 27 2 2021
medline: 26 3 2021
entrez: 26 2 2021
Statut: ppublish

Résumé

During the 2020 COVID-19 pandemic there was a decrease in emergency room arrivals. There is limited evidence about the effect of this change in behavior on women's health. We aimed to evaluate the impact of the COVID-19 pandemic on the diagnosis, treatment and complications of women presenting with a tubal Ectopic Pregnancy (EP). This is a single centre retrospective cohort study. We compared the clinical presentation, treatment modalities and complications of all women presenting in our institution with a tubal EP during the COVID-19 pandemic between 15 March and 15 June 2020, with women who were treated in our institution with the same diagnosis in the corresponding period for the years 2018-2019. The study group included 19 cases of EP (N = 19) that were treated between the 15 March 2020 and 15 June 2020. The control group included 30 cases of EP (N = 30) that were admitted to in the corresponding period during 2018 and 2019. Maternal age, parity, gravity and mode of conception (natural vs. assisted) were similar between the two groups. There was no difference in the mean gestational age (GA) according to the last menstrual period. In the study group more women presented with sonographic evaluation of high fluid volume in the abdomen than in the control group (53 % vs 17 %, P value 0.01). This finding is correlated with a more advanced disease status. In the study group there was a highly statistically significant 3-fold increase in rupture among cases (P < 0.005) and a 4-fold larger volume of blood in the entrance to the abdomen (P < 0.002). We found that there were no cases of ruptured EP in the group of women who were pregnant after assisted reproduction. We found a higher rate of ruptured ectopic pregnancies in our institution during the COVID-19 pandemic. Health care providers should be alerted to this collateral damage in the non-infected population during the COVID-19 pandemic.

Identifiants

pubmed: 33636621
pii: S0301-2115(21)00068-3
doi: 10.1016/j.ejogrb.2021.01.054
pmc: PMC7968738
pii:
doi:

Substances chimiques

Abortifacient Agents, Nonsteroidal 0
Chorionic Gonadotropin, beta Subunit, Human 0
Methotrexate YL5FZ2Y5U1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

95-99

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Références

J Epidemiol Community Health. 2003 Nov;57(11):864-70
pubmed: 14600111
Obstet Gynecol. 2011 Apr;117(4):837-843
pubmed: 21422853
Obstet Gynecol. 2008 Jun;111(6):1479-85
pubmed: 18515537
Hum Reprod Update. 2008 Jul-Aug;14(4):309-19
pubmed: 18522946
Obstet Gynecol. 2010 Dec;116(6):1302-1309
pubmed: 21099595
Int J Health Policy Manag. 2018 Nov 21;8(3):158-167
pubmed: 30980632
Semin Reprod Med. 2007 Mar;25(2):93-8
pubmed: 17377896
Obstet Gynecol Surv. 2013 Aug;68(8):571-81
pubmed: 23921671
N Engl J Med. 2020 Jun 18;382(25):e100
pubmed: 32302077
Lancet Child Adolesc Health. 2020 May;4(5):e10-e11
pubmed: 32278365
Am J Obstet Gynecol. 1999 Apr;180(4):938-44
pubmed: 10203662
Hum Reprod. 2002 Dec;17(12):3224-30
pubmed: 12456628
BMC Pediatr. 2020 Sep 7;20(1):427
pubmed: 32894080
Fertil Steril. 2013 Sep;100(3):638-44
pubmed: 23849842

Auteurs

Shira Dvash (S)

Department of Obstetrics and Gynecology, The Yitzhak Shamir Medical Center (Formerly Assaf Harofeh Medical Center), Zerifin 70300, Israel; Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Howard Cuckle (H)

Department of Obstetrics and Gynecology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Noam Smorgick (N)

Department of Obstetrics and Gynecology, The Yitzhak Shamir Medical Center (Formerly Assaf Harofeh Medical Center), Zerifin 70300, Israel; Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Zvi Vaknin (Z)

Department of Obstetrics and Gynecology, The Yitzhak Shamir Medical Center (Formerly Assaf Harofeh Medical Center), Zerifin 70300, Israel; Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Anna Padoa (A)

Department of Obstetrics and Gynecology, The Yitzhak Shamir Medical Center (Formerly Assaf Harofeh Medical Center), Zerifin 70300, Israel; Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ron Maymon (R)

Department of Obstetrics and Gynecology, The Yitzhak Shamir Medical Center (Formerly Assaf Harofeh Medical Center), Zerifin 70300, Israel; Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: RonM@Shamir.gov.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH